Torrent Pharmaceuticals has achieved a significant milestone as the US Food and Drug Administration (USFDA) concluded its inspection of the company’s Dahej manufacturing facility with zero observations. This clean report strengthens Torrent’s compliance credibility, paving the way for faster product approvals and enhanced growth prospects in the US generics market.
Show moreStay Ahead – Explore Now! Gufic Biosciences Navigates Rs. 4.33 Crore Tax Disallowance With Optimism
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
